Actionable news
0
All posts from Actionable news
Actionable news in SNY: SANOFI,

Genzyme reports positive long-term data for multiple sclerosis treatment

Oct 8 Genzyme, the rare disease unit of French drug company Sanofi, said on Thursday five-year investigational data from the extension study of its medication Lemtrada, sold in Europe and the United States, had shown positive results for patients with relapsing remitting multiple sclerosis.

"The (positive) effects (...) observed in the two-year trials were maintained through three additional years in the extension study (years three, four and five),"...


More